PMID- 38313078 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240210 IS - 2752-4191 (Electronic) IS - 2752-4191 (Linking) VI - 4 IP - 1 DP - 2024 Jan TI - The impact of extracorporeal membrane oxygenation on mortality in patients with cardiogenic shock post-acute myocardial infarction: a systematic review and meta-analysis. PG - oeae003 LID - 10.1093/ehjopen/oeae003 [doi] LID - oeae003 AB - AIMS: Cardiogenic shock remains the leading cause of death in patients hospitalized with acute myocardial infarction. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used in the treatment of infarct-related cardiogenic shock. However, there is limited evidence regarding its beneficial impact on mortality. The aim of this study was to systematically review studies reporting the impact of VA-ECMO on mortality in patients with acute myocardial infarction complicated by cardiogenic shock. METHODS AND RESULTS: A comprehensive search of medical databases (Cochrane Register and PubMed) was conducted. Studies that reported mortality outcomes in patients treated with VA-ECMO for infarct-related cardiogenic shock were included. The database search yielded 1194 results, of which 11 studies were included in the systematic review. Four of these studies, with a total of 586 patients, were randomized controlled trials and were included in the meta-analysis. This demonstrated that there was no significant difference in 30-day all-cause mortality with the use of VA-ECMO compared with standard medical therapy [odds ratio (OR) 0.91; 95% confidence interval (CI) 0.65-1.27]. Meta-analysis of two studies showed that VA-ECMO was associated with a significant reduction in 12-month all-cause mortality (OR 0.31; 95% CI 0.11-0.86). Qualitative synthesis of the observational studies showed that age, serum creatinine, serum lactate, and successful revascularization are independent predictors of mortality. CONCLUSION: Veno-arterial extracorporeal membrane oxygenation does not improve 30-day all-cause mortality in patients with cardiogenic shock following acute myocardial infarction; however, there may be significant reduction in all-cause mortality at 12 months. Further studies are needed to delineate the potential benefit of VA-ECMO in long-term outcomes. REGISTRATION: The protocol was registered in the PROSPERO International Prospective Register of Systematic Reviews (ID: CRD42023461740). CI - (c) The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. FAU - Paddock, Sophie AU - Paddock S AUID- ORCID: 0000-0002-1163-9710 AD - Cardiology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK. AD - Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. FAU - Meng, James AU - Meng J AD - Cardiology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK. AD - Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. FAU - Johnson, Nicholas AU - Johnson N AD - Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. FAU - Chattopadhyay, Rahul AU - Chattopadhyay R AD - Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. AD - Cardiology Department, Cambridge University Hospital, Cambridge, UK. FAU - Tsampasian, Vasiliki AU - Tsampasian V AD - Cardiology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK. AD - Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. FAU - Vassiliou, Vassilios AU - Vassiliou V AUID- ORCID: 0000-0002-4005-7752 AD - Cardiology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK. AD - Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. LA - eng GR - WT_/Wellcome Trust/United Kingdom PT - Journal Article DEP - 20240118 PL - England TA - Eur Heart J Open JT - European heart journal open JID - 9918282081406676 PMC - PMC10836884 OTO - NOTNLM OT - Acute myocardial infarction OT - Cardiogenic shock OT - Extracorporeal membrane oxygenation COIS- Conflict of interest: There are no conflicts of interest related to this work. EDAT- 2024/02/05 06:44 MHDA- 2024/02/05 06:45 PMCR- 2024/01/18 CRDT- 2024/02/05 04:31 PHST- 2023/10/27 00:00 [received] PHST- 2023/11/29 00:00 [revised] PHST- 2024/01/14 00:00 [accepted] PHST- 2024/02/05 06:45 [medline] PHST- 2024/02/05 06:44 [pubmed] PHST- 2024/02/05 04:31 [entrez] PHST- 2024/01/18 00:00 [pmc-release] AID - oeae003 [pii] AID - 10.1093/ehjopen/oeae003 [doi] PST - epublish SO - Eur Heart J Open. 2024 Jan 18;4(1):oeae003. doi: 10.1093/ehjopen/oeae003. eCollection 2024 Jan.